Top 5 Cancer Screenings That Should be on Your Radar in 2024

Cannabis and cannabinoid access and use among patients with cancer “has outpaced the science supporting their clinical use,” according to the findings issued by an expert panel convened by the American Society of Clinical Oncology (ASCO).

Adjuvant therapy with aspirin offers no protection against recurrence or survival benefit in patients with high-risk nonmetastatic breast cancer, the results of a new phase 3 randomized controlled trial suggest.

It takes a certain amount of confidence to call your biotech company Grail.

New research suggests patients with an average risk of colon cancer may only need to undergo a colonoscopy screening every 15 years instead of the recommended 10.